Association study between norepinephrine transporter gene polymorphism and schizophrenia in a Korean population

Mira Choo, Jung A. Hwang, Sang Won Jeon, So Young Oh, Ho-Kyoung Yoon, Heon-Jeong Lee, Yong Ku Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective : We aimed to investigate possible associations between three norepinephrine transporter gene (SLC6A2) single nucleotide polymorphisms (T182C, A3081T, and G1287A) and schizophrenia. Also, we investigated the relationships of those polymorphisms with clinical severity and characteristics of schizophrenia. Methods : Participants were 220 schizophrenia patients in the acute phase and 167 healthy controls. The genotype, allele frequency, and haplotype of each group were analyzed for T182C, A3081T, and G1287A polymorphisms. Of the 220 schizophrenia patients, 163 patients were evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Korean version of the Calgary depression scale for schizophrenia (K-CDSS) at baseline. Results : We found no significant differences between the schizophrenia patient group and the control group in genotype distribution or allele frequency of the three tested polymorphisms. Likewise, we could not find any significant differences in genotype or allele frequency by analyzing according to gender. In the haplotype study, no significant association emerged between specific haplotype combinations and schizophrenia. We also found no association between clinical scales (PANSS and K-CDSS) and the studied polymorphisms. Conclusion : Our results suggest that the investigated polymorphisms of the NET gene are not associated with susceptibility to schizophrenia or its clinical features in a Korean population. However, this study remains significant because it is the first haplotype study to investigate associations between NET gene (SLC6A2) single nucleotide polymorphisms and schizophrenia in a Korean population. Future research with a larger sample size and more genetic markers is needed to replicate our results.

Original languageEnglish
Pages (from-to)551-558
Number of pages8
JournalPsychiatry Investigation
Volume12
Issue number4
DOIs
Publication statusPublished - 2015 Oct 1

Fingerprint

Norepinephrine Plasma Membrane Transport Proteins
Schizophrenia
Population
Genes
Haplotypes
Gene Frequency
Genotype
Single Nucleotide Polymorphism
Depression
Genetic Markers
Sample Size

Keywords

  • Gene
  • NET gene
  • Schizophrenia
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Association study between norepinephrine transporter gene polymorphism and schizophrenia in a Korean population. / Choo, Mira; Hwang, Jung A.; Jeon, Sang Won; Oh, So Young; Yoon, Ho-Kyoung; Lee, Heon-Jeong; Kim, Yong Ku.

In: Psychiatry Investigation, Vol. 12, No. 4, 01.10.2015, p. 551-558.

Research output: Contribution to journalArticle

@article{9ee1a345769c4cc890c280ce55dac7f2,
title = "Association study between norepinephrine transporter gene polymorphism and schizophrenia in a Korean population",
abstract = "Objective : We aimed to investigate possible associations between three norepinephrine transporter gene (SLC6A2) single nucleotide polymorphisms (T182C, A3081T, and G1287A) and schizophrenia. Also, we investigated the relationships of those polymorphisms with clinical severity and characteristics of schizophrenia. Methods : Participants were 220 schizophrenia patients in the acute phase and 167 healthy controls. The genotype, allele frequency, and haplotype of each group were analyzed for T182C, A3081T, and G1287A polymorphisms. Of the 220 schizophrenia patients, 163 patients were evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Korean version of the Calgary depression scale for schizophrenia (K-CDSS) at baseline. Results : We found no significant differences between the schizophrenia patient group and the control group in genotype distribution or allele frequency of the three tested polymorphisms. Likewise, we could not find any significant differences in genotype or allele frequency by analyzing according to gender. In the haplotype study, no significant association emerged between specific haplotype combinations and schizophrenia. We also found no association between clinical scales (PANSS and K-CDSS) and the studied polymorphisms. Conclusion : Our results suggest that the investigated polymorphisms of the NET gene are not associated with susceptibility to schizophrenia or its clinical features in a Korean population. However, this study remains significant because it is the first haplotype study to investigate associations between NET gene (SLC6A2) single nucleotide polymorphisms and schizophrenia in a Korean population. Future research with a larger sample size and more genetic markers is needed to replicate our results.",
keywords = "Gene, NET gene, Schizophrenia, Single nucleotide polymorphism",
author = "Mira Choo and Hwang, {Jung A.} and Jeon, {Sang Won} and Oh, {So Young} and Ho-Kyoung Yoon and Heon-Jeong Lee and Kim, {Yong Ku}",
year = "2015",
month = "10",
day = "1",
doi = "10.4306/pi.2015.12.4.551",
language = "English",
volume = "12",
pages = "551--558",
journal = "Psychiatry Investigation",
issn = "1738-3684",
publisher = "Korean Neuropsychiatric Association",
number = "4",

}

TY - JOUR

T1 - Association study between norepinephrine transporter gene polymorphism and schizophrenia in a Korean population

AU - Choo, Mira

AU - Hwang, Jung A.

AU - Jeon, Sang Won

AU - Oh, So Young

AU - Yoon, Ho-Kyoung

AU - Lee, Heon-Jeong

AU - Kim, Yong Ku

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Objective : We aimed to investigate possible associations between three norepinephrine transporter gene (SLC6A2) single nucleotide polymorphisms (T182C, A3081T, and G1287A) and schizophrenia. Also, we investigated the relationships of those polymorphisms with clinical severity and characteristics of schizophrenia. Methods : Participants were 220 schizophrenia patients in the acute phase and 167 healthy controls. The genotype, allele frequency, and haplotype of each group were analyzed for T182C, A3081T, and G1287A polymorphisms. Of the 220 schizophrenia patients, 163 patients were evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Korean version of the Calgary depression scale for schizophrenia (K-CDSS) at baseline. Results : We found no significant differences between the schizophrenia patient group and the control group in genotype distribution or allele frequency of the three tested polymorphisms. Likewise, we could not find any significant differences in genotype or allele frequency by analyzing according to gender. In the haplotype study, no significant association emerged between specific haplotype combinations and schizophrenia. We also found no association between clinical scales (PANSS and K-CDSS) and the studied polymorphisms. Conclusion : Our results suggest that the investigated polymorphisms of the NET gene are not associated with susceptibility to schizophrenia or its clinical features in a Korean population. However, this study remains significant because it is the first haplotype study to investigate associations between NET gene (SLC6A2) single nucleotide polymorphisms and schizophrenia in a Korean population. Future research with a larger sample size and more genetic markers is needed to replicate our results.

AB - Objective : We aimed to investigate possible associations between three norepinephrine transporter gene (SLC6A2) single nucleotide polymorphisms (T182C, A3081T, and G1287A) and schizophrenia. Also, we investigated the relationships of those polymorphisms with clinical severity and characteristics of schizophrenia. Methods : Participants were 220 schizophrenia patients in the acute phase and 167 healthy controls. The genotype, allele frequency, and haplotype of each group were analyzed for T182C, A3081T, and G1287A polymorphisms. Of the 220 schizophrenia patients, 163 patients were evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Korean version of the Calgary depression scale for schizophrenia (K-CDSS) at baseline. Results : We found no significant differences between the schizophrenia patient group and the control group in genotype distribution or allele frequency of the three tested polymorphisms. Likewise, we could not find any significant differences in genotype or allele frequency by analyzing according to gender. In the haplotype study, no significant association emerged between specific haplotype combinations and schizophrenia. We also found no association between clinical scales (PANSS and K-CDSS) and the studied polymorphisms. Conclusion : Our results suggest that the investigated polymorphisms of the NET gene are not associated with susceptibility to schizophrenia or its clinical features in a Korean population. However, this study remains significant because it is the first haplotype study to investigate associations between NET gene (SLC6A2) single nucleotide polymorphisms and schizophrenia in a Korean population. Future research with a larger sample size and more genetic markers is needed to replicate our results.

KW - Gene

KW - NET gene

KW - Schizophrenia

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=84946557236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946557236&partnerID=8YFLogxK

U2 - 10.4306/pi.2015.12.4.551

DO - 10.4306/pi.2015.12.4.551

M3 - Article

AN - SCOPUS:84946557236

VL - 12

SP - 551

EP - 558

JO - Psychiatry Investigation

JF - Psychiatry Investigation

SN - 1738-3684

IS - 4

ER -